# Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia

> **NCT04094207** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sadat City University** · enrollment: 80 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Placebo oral tablet
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT04094207
- **Lead sponsor:** Sadat City University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094207, "Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04094207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*